KRAS
Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28